Selected article for: "acute respiratory infection and cohort study"

Author: Bersanelli, Melissa; Zielli, Teresa; Perrone, Fabiana; Casartelli, Chiara; Pratticò, Fabiana; Rapacchi, Elena; Camisa, Roberta; Tognetto, Michele; Clemente, Alberto; Giannarelli, Diana; Rebuzzi, Sara Elena; Leonetti, Alessandro; Bordi, Paola; Tiseo, Marcello; Buti, Sebastiano
Title: Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy
  • Cord-id: 0bmcw303
  • Document date: 2020_9_16
  • ID: 0bmcw303
    Snippet: Aim: Evaluating the incidence and course of COVID-19 in cancer patients treated with immunotherapy. Patients & methods: We reported the influenza-like illness events with diagnosis of COVID-19 within the patient cohort enrolled in the prospective observational multicenter INVIDIa-2 study in the single center of Parma. Results: Among 53 patients, eight experienced influenza-like illness during the influenza season 2019/2020, and three of them had diagnosis of COVID-19. They were males, elderly, w
    Document: Aim: Evaluating the incidence and course of COVID-19 in cancer patients treated with immunotherapy. Patients & methods: We reported the influenza-like illness events with diagnosis of COVID-19 within the patient cohort enrolled in the prospective observational multicenter INVIDIa-2 study in the single center of Parma. Results: Among 53 patients, eight experienced influenza-like illness during the influenza season 2019/2020, and three of them had diagnosis of COVID-19. They were males, elderly, with cardiovascular disease. Radiological features of COVID-19 pneumonitis were found in all of three cases, although the pharyngeal swab resulted positive in only two. Two of these three patients died due to respiratory failure. Conclusion: Cancer patients are at high risk of severe events from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

    Search related documents:
    Co phrase search for related documents
    • action different mechanism and acute respiratory distress syndrome: 1
    • active infection and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • active infection and long follow: 1, 2
    • active infection and low grade fever: 1
    • active infection and lung cancer: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory distress syndrome and local ethical committee: 1
    • acute respiratory distress syndrome and long follow: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory distress syndrome and low grade fever: 1, 2, 3, 4, 5
    • acute respiratory distress syndrome and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • locally advanced and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • locally advanced disease and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8
    • long follow and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12